Brief: PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
25/03/2025 12:21
March 25 (Reuters) - PAVmed Inc PAVM.O: PAVMED INC: QTRLY EPS $0.12 Source text: ID:nPn8cNKSHa Further company coverage: PAVM.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on PAVmed
See all newsBrief: Lucid Diagnostics Begins Receiving Medicare Reimbursement For Esoguard® And Closes $15 Million Financing
PAVmed Inc reports results for the quarter ended June 30 - Earnings Summary
PAVmed Inc expected to post a loss of 47 cents a share - Earnings Preview
NASDAQ RESUMED AT 11:36 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:21 AM